News | Radiation Therapy | July 21, 2017

El Camino Hospital to Offer Calypso 4-D Localization System

FDA-approved device targets more soft tissue cancers using precise technology

El Camino Hospital to Offer Calypso 4-D Localization System

July 21, 2017 — El Camino Hospital (Mountain View, Calif.) announced the installation of a new Calypso 4-D Localization System and will soon be able to treat patients with certain soft tissue cancers using this precise radiation technology.

The Calypso system is a radiation therapy treatment device that allows for real-time tracking of tumors as they move within a patient’s soft tissues. It has been in use for a decade to treat prostate cancer, however it was only recently approved by the U.S. Food and Drug Administration (FDA) for use against other soft tissue cancers, such as pancreatic, breast, liver, lung, gynecological and more. El Camino Hospital will be the first hospital in the San Francisco Bay Area to expand the Calypso’s use to other cancer sites.

“Our biggest challenge as radiation oncologists is that our targets, the tumors, in the body move,” said Robert Sinha, M.D., medical director of radiation oncology at El Camino Hospital. “The only equipment that allows you to track that movement continuously is the Calypso system. By using its precise tracking technology, we can confidently keep the radiation beam on the tumor and therefore, irradiate less normal tissue.

“While this process has been well established for use against prostate cancer, its approval for expanded use on other soft tissue cancers is groundbreaking for our patients. Its targeted image guidance will improve the patient experience and allow doctors to consistently target only tumor tissue, reducing the side effects of radiation therapy,” he added.

The new device was funded by the El Camino Hospital Foundation. In addition to the Calypso system, El Camino Hospital oncologists have access to radiation therapy technology that includes the CyberKnife, RapidArc, intensity-modulated radiation therapy (IMRT), brachytherapy and more. The Cancer Center at El Camino Hospital offers numerous radiation treatment options and works with each patient to create a unique plan that will work best for them.

For more information: www.varian.com

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...